University of California, San Francisco
San Francisco, California, 94143, United States
NCT Number: NCT00319943
The purpose of this study is to determine the neuropsychological and neurophysiological impacts of a computer-based training program designed to improve the cognitive performance of patients with mild cognitive impairment (MCI).
Looking for future studies?
Notify Me65 year–90 year
All sexes
Interventional
Phase 1
San Francisco, California, 94143, United States
The study is a randomized, double-blind, controlled trial of a computerized, cognitive intervention with three main goals: 1) to assess the magnitude of improvements in memory, language function, and cognitive function following computer training, 2) to investigate the neurophysiological mechanisms underlying such neuropsychological improvements, and 3) to demonstrate the feasibility of using this kind of computer-based therapy in older populations.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
1)65 - 90 years of age 2)Meet definition for MCI including complaints of cognitive decline as indicated by patient report and/or informant report, and corroborated by clinician judgment and, the absence of dementia, defined as impairment of memory and at least one other domain of cognitive function.
3)Fluency in English 4)Willing to meet the time commitment of the study
-
Exclusion criteria
Posit Science Corporation
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06347172
Alzheimer Disease, Brain Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT04070703
Cognition Disorders, Cognitive Dysfunction
Eugene, Oregon, United States
View Trial DetailsNCT07554144
Adolescent Development, Attention Impaired
Kütahya, Centre, Turkey (Türkiye)
View Trial DetailsNCT07729865
Cognition Disorders, Cognitive Dysfunction
Lahore, Punjab Province, Pakistan
View Trial Details